2185 — Shanghai Bio-heart Biological Technology Co Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$443.97m
- HK$169.39m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -23.7 | -340 | -410 | -231 | -189 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.07 | 284 | 325 | 118 | 72.7 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -5.41 | -0.941 | -16.9 | -48.5 | 45.7 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -21.4 | -48.5 | -88.5 | -141 | -49 |
Capital Expenditures | -15 | -5.75 | -34.7 | -30 | -18 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 9.33 | -219 | 0.972 | -70.6 | -10.9 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -5.66 | -225 | -33.7 | -101 | -28.9 |
Financing Cash Flow Items | 39.2 | 730 | -7.27 | -2.15 | -0.561 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 43.1 | 723 | 384 | -35.2 | -5.82 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 16.1 | 433 | 255 | -257 | -81.9 |